The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; GOG Foundation; ImmunoGen; Iovance Biotherapeutics; Janssen; Merck; Mersana; Novocure; Regeneron; SDP Oncology; Seagan; Tesaro/GSK
Research Funding - Abbvie; Ajinomoto; Amgen; Array BioPharma; AstraZeneca; BioPharma Services; Bristol Myers Squibb Foundation; Cerulean Pharma; Clovis Oncology; Eisai; EMD Serono; Ergomed; Genentech/Roche; Genmab; GOG Foundation; ImmunoGen; Inc Research; inVentiv Health; Iovance Biotherapeutics; Janssen; Ludwig Institute for Cancer Research; Merck; Mersana; New Mexico Cancer Center; Novocure; PRA Intl; Regeneron; SDP Oncology; Seagan; Stem CentRx; Tesaro/GSK; TRACON Pharma; VentiRx; Yale University
Travel, Accommodations, Expenses - Agenus; Ambry Genetics; Arquer Diagnostics; Celsion; Corcept Therapeutics; Elevar Therapeutics; InxMed; Myriad Genetics; Novartis; Roche; Rubius Therapeutics; Sorrento Therapeutics; Takeda; Tarveda Therapeutics; Toray Industries
Predictors of long-term progression-free survival (PFS) in niraparib-treated patients (pts) from the PRIMA/ENGOT-OV26/GOG-3012 study.
 
Whitney Graybill
Consulting or Advisory Role - Eisai; GlaxoSmithKline
Speakers' Bureau - GlaxoSmithKline
 
Beatriz Pardo
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
 
David M. O'Malley
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - Agenus; Akeso Biopharma; AstraZeneca; Bristol Myers Squibb; Deciphera; Eisai; Elevar Therapeutics; Exelixis; Genmab; GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Mersana; MSD; Novartis; Novocure; Oncoinvent; OncXerna Therapeutics; Regeneron; Roche; Sanofi; Seagen; Sotio; Verastem; Zentalis
Research Funding - Amgen (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genmab; Karyopharm Therapeutics; Novocure
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Macrogenics; Merck; Mersana; Myriad Pharmaceuticals; Novartis; Novocure; OncoC4; Pfizer; Pieris Pharmaceuticals; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Consulting or Advisory Role - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Merck; Mersana; Myriad Pharmaceuticals; Novartis; Novocure; OncoC4; Pfizer; Pieris Pharmaceuticals; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Annika Auranen
Consulting or Advisory Role - GlaxoSmithKline
 
Larry J. Copeland
Consulting or Advisory Role - Celsion; Corcept Therapeutics; Elevar Therapeutics; GlaxoSmithKline; Immunogen; InxMed; Myriad Genetics; Onconova Therapeutics; Rubius Therapeutics; Sorrento Therapeutics; Toray Industries; VBL Therapeutics
 
Roberto Sabbitini
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - MSD
 
Thomas J Herzog
Leadership - GOG Foundation
Consulting or Advisory Role - AstraZeneca; Caris MPI; Clovis Oncology; Corcept Therapeutics; Eisai; Epsilogen; Genelux; Genentech; GlaxoSmithKline; ImmunoGen; Johnson & Johnson; Merck; Mersana; Seagan; Sutro Biopharma
 
Philippe Follana
Honoraria - AstraZeneca; Clovis Oncology; Daiichi Sankyo Pharmaceutical; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; GlaxoSmithKline; Novartis
 
Bhavana Pothuri
Honoraria - Bio Ascend; OncLive; PER; Projects in Knowledge
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Immunogen; Lilly; Merck; Mersana; Seagen; Signatera; Sutro Biopharma
Research Funding - Agenus (Inst); AstraZeneca (Inst); Celgene (Inst); Celsion (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Incyte (Inst); InxMed (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mersana (Inst); Novocure (Inst); NRG Oncology (Inst); Seagen (Inst); Sutro Biopharma (Inst); Takeda (Inst); Tesaro (Inst); Toray Industries (Inst); VBL Therapeutics (Inst)
Travel, Accommodations, Expenses - GOG Foundation; Merck; Seagen
Other Relationship - Society of Gynecologic Oncology
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; ImmunoGen; MSD; Roche; Takeda
Research Funding - Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD; Roche
 
Colleen McCormick
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck
Speakers' Bureau - AstraZeneca
 
Alfonso Yubero-Esteban
Research Funding - GlaxoSmithKline
 
Richard G. Moore
Honoraria - Fujirebio Diagnostics; GlaxoSmithKline
Consulting or Advisory Role - Fujirebio Diagnostics
Research Funding - Angle
 
Peter Vuylsteke
Honoraria - MSD Oncology; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Roche
 
Nicoline Raashouu-Jensen
No Relationships to Disclose
 
Whitney York
Employment - GlaxoSmithKline
 
John Hartman
Employment - GlaxoSmithKline
 
Antonio Gonzalez Martin
Consulting or Advisory Role - Alkermes; Amgen; AstraZeneca; Clovis Oncology; Genmab; Hedera Dx; Immunogen; Macrogenics; Mersana; MSD; Novartis; Novocure; Oncoinvent; Pfizer/EMD Serono; Roche; Seagen; SOTIO; Sutro Biopharma; Takeda; Tesaro/GSK
Speakers' Bureau - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro/GSK
Research Funding - Roche (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; PharmaMar; Roche; Tesaro/GSK